Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026)

Denali Therapeutics (DNLI) has 10 years of Prepaid Assets data on file, last reported at $35.1 million in Q1 2026.

• Quarterly Prepaid Assets fell 42.24% year-over-year to $35.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (down 42.24% YoY) and the FY2025 annual result came in at $32.8 million, up 2.1% from the prior year.
• Prepaid Assets climbed to $35.1 million in Q1 2026 per DNLI's latest filing, from $32.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $60.7 million in Q1 2025 and bottomed at $29.6 million in Q4 2023.
• The 5-year median for Prepaid Assets is $33.6 million (2023), against an average of $35.9 million.
• The widest annual swing landed in 2022, when Prepaid Assets jumped 184.33%; it then sank 42.24% in 2026.
• Tracing DNLI's Prepaid Assets over 5 years: stood at $36.1 million in 2022, then fell by 17.94% to $29.6 million in 2023, then increased by 8.37% to $32.1 million in 2024, then advanced by 2.1% to $32.8 million in 2025, then grew by 6.98% to $35.1 million in 2026.
• Per Business Quant, the three latest DNLI Prepaid Assets figures stand at $35.1 million (Q1 2026), $32.8 million (Q4 2025), and $34.4 million (Q3 2025).

Peer Comparison